Cargando…
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
Local treatment of the axilla in clinically node-negative (cN0) early breast cancer patients with routine sentinel lymph node biopsy (SLNB) is debated after publication of ACOSOG Z0011 data in 2010. Currently, prospective randomized surgical trials investigating the omission of SLNB in upfront breas...
Autor principal: | Reimer, Toralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982316/ https://www.ncbi.nlm.nih.gov/pubmed/36658052 http://dx.doi.org/10.1016/j.breast.2023.01.002 |
Ejemplares similares
-
Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023) -
Tailored axillary surgery – A novel concept for clinically node positive breast cancer
por: Heidinger, Martin, et al.
Publicado: (2023) -
This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients
por: van Hemert, Annemiek K.E., et al.
Publicado: (2023) -
Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients
por: Boersma, Liesbeth J., et al.
Publicado: (2023) -
Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)